Y-Intercept (HK)’s Cardlytics CDLX Stock Holding History

Y-Intercept (HK)’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,579	Closed	-$42.4K	–	1606
2025 Q2	$42.4K	Buy	+2,579	New	+$44.5K	﹤0.01%	1565
2024 Q2	–	Sell	-3,366	Closed	-$488K	–	1446
2024 Q1	$488K	Buy	3,366 +2,049	+156%	+$173K	0.04%	724
2023 Q4	$121K	Buy	+1,317	New	+$134K	0.01%	1073

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Y-Intercept (HK)'s CDLX Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 2,579 shares — an estimated $42.4K sold.

Y-Intercept (HK) first reported a position in CDLX in Q4 2023 and held it in 3 quarters. The position peaked at $488K in Q1 2024. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

Y-Intercept (HK) reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 2,579 Cardlytics shares in Q3 2025, an estimated $42.4K.
Y-Intercept (HK) first reported a position in Cardlytics in Q4 2023 and held it in 3 quarters.
Y-Intercept (HK)'s Cardlytics position peaked at $488K in Q1 2024.
81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.